Arunjyoti Bio Ventures Ltd
Fundamental Score
Arunjyoti Bio Ventures Ltd Share Price Live NSE/BSE
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of ABVL across key market metrics for learning purposes.
Positive Indicators
2 factors identified
Consistent Growth Track Record (32.84% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model and market opportunity execution over time.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral, reducing forced-selling risk.
Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.
Risk Factors
9 factors identified
Below-Average Return on Equity (-10.66%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (4.03%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation. Review business model and competitive positioning.
Profit Decline Concern (-459.09%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes. Monitor for recovery signs and management guidance.
Revenue Contraction (-15.91%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions and competitive positioning. Monitor recovery strategies.
Weak Interest Coverage (0.59x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability. Monitor cash flow and debt reduction plans.
Negative Free Cash Flow (₹-54.08 Cr over 5Y)
Observation: Cash outflows exceed inflows, indicating capital intensity or working capital issues.
Analysis: Negative FCF requires analysis of capital expenditure cycle and working capital management efficiency.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints. Assess capital allocation strategy.
Very Low ROE
Observation: Poor capital utilization and shareholder returns.
Analysis: ROE below 5% suggests significant inefficiencies in capital deployment.
Small Market Cap
Observation: Higher investment risk due to limited size.
Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.
Financial Statements
Comprehensive financial data for Arunjyoti Bio Ventures Ltd
About ABVL
Business Overview
Arunjyothi Bio Ventures Limited provides co-packing services in India. It serves beverage and non-carbonated water industries. The company was formerly known as Century 21st Portfolio Limited and changed its name to Arunjyothi Bio Ventures Limited in 2014. The company was incorporated in 1986 and is based in Hyderabad, India.
Company Details
Key Leadership
ABVL Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of Arunjyoti Bio Ventures Ltd (ABVL)?
As of 29 Jan 2026, 10:34 am IST, Arunjyoti Bio Ventures Ltd (ABVL) is currently trading at ₹7.20. The stock has a market capitalization of ₹140.90 (Cr).
Is ABVL share price Overvalued or Undervalued?
ABVL is currently trading at a P/E ratio of 0.00x, compared to the industry average of 30.94x. Based on this relative valuation, the stock appears to be Fairly Valued against its sector peers.
What factors affect the Arunjyoti Bio Ventures Ltd share price?
Key factors influencing ABVL's price include its quarterly earnings growth (Sales Growth: -15.91%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Arunjyoti Bio Ventures Ltd a good stock for long-term investment?
Arunjyoti Bio Ventures Ltd shows a 5-year Profit Growth of N/A% and an ROE of -10.66%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.71 before investing.
How does Arunjyoti Bio Ventures Ltd compare with its industry peers?
Arunjyoti Bio Ventures Ltd competes with major peers in the Other Financial Services. Investors should compare ABVL's P/E of 0.00x and ROE of -10.66% against the industry averages to determine its competitive standing.
What is the P/E ratio of ABVL and what does it mean?
ABVL has a P/E ratio of N/Ax compared to the industry average of 30.94x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹N/A for every ₹1 of annual earnings.
How is ABVL performing according to Bull Run's analysis?
ABVL has a Bull Run fundamental score of 18.9/100, which indicates concerns that require careful analysis. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.
What sector and industry does ABVL belong to?
ABVL operates in the Other Financial Services industry. This classification helps understand the competitive landscape and sector-specific trends affecting Arunjyoti Bio Ventures Ltd.
What is Return on Equity (ROE) and why is it important for ABVL?
ABVL has an ROE of -10.66%, which suggests challenges in generating returns from shareholders' equity. Return on Equity measures how efficiently Arunjyoti Bio Ventures Ltd generates profits from shareholders' equity.
How is ABVL's debt-to-equity ratio and what does it indicate?
ABVL has a debt-to-equity ratio of 0.71, which indicates moderate leverage that should be monitored. A ratio below 1.0 generally indicates conservative financing.
What is ABVL's dividend yield and is it a good dividend stock?
ABVL offers a dividend yield of 0.00%, which means you receive ₹0.00 annual dividend for every ₹100 invested.
How has ABVL grown over the past 5 years?
ABVL has achieved 5-year growth rates of: Sales Growth 32.84%, Profit Growth N/A%, and EPS Growth N/A%.
What is the promoter holding in ABVL and why does it matter?
Promoters hold 47.64% of ABVL shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.
What is ABVL's market capitalization category?
ABVL has a market capitalization of ₹141 crores, placing it in the Small-cap category.
How volatile is ABVL stock?
ABVL has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is the 52-week high and low for ABVL?
ABVL has a 52-week high of ₹N/A and low of ₹N/A.
What is ABVL's operating profit margin trend?
ABVL has a 5-year average Operating Profit Margin (OPM) of 13.45%, indicating the company's operational efficiency.
How is ABVL's quarterly performance?
Recent quarterly performance shows YoY Sales Growth of -15.91% and YoY Profit Growth of -459.09%.
What is the institutional holding pattern in ABVL?
ABVL has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the stock.